Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 9,575 | 12,054 | 9,466 | 9,135 | 9,153 |
| Cost of Goods | 1,890 | 2,050 | 2,370 | 2,610 | 2,240 |
| Gross Profit | 7,680 | 10,000 | 7,110 | 6,520 | 6,910 |
| Operating Expenses | 13,760 | 10,370 | 12,420 | 11,730 | 12,880 |
| Operating Income | -5,185 | -316 | -4,954 | -4,595 | -5,727 |
| Interest Expense | 0 | 0 | 10 | 0 | 0 |
| Other Income | 55 | 46 | 274 | 635 | 407 |
| Pre-tax Income | -5,130 | -270 | -4,690 | -3,960 | -5,320 |
| Income Tax | -1,580 | -1,460 | -1,960 | -1,650 | -1,960 |
| Net Income Continuous | -3,550 | 1,190 | -2,726 | -2,304 | -3,358 |
| Net Income | $-3,550 | $1,190 | $-2,726 | $-2,304 | $-3,358 |
| EPS Basic Total Ops | -0.15 | 0.05 | -0.11 | -0.10 | -0.14 |
| EPS Basic Continuous Ops | -0.15 | 0.05 | -0.11 | -0.10 | -0.14 |
| EPS Diluted Total Ops | -0.15 | 0.05 | -0.11 | -0.10 | -0.14 |
| EPS Diluted Continuous Ops | -0.15 | 0.05 | -0.11 | -0.10 | -0.14 |
| EBITDA(a) | $-3,695 | $1,154 | $-3,244 | $-2,855 | $-3,577 |